FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

32868611000001107: Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jul 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100192301000001112 Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100192401000001116 Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet Is a Acamprosate 333mg gastro-resistant tablets 168 tablet true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet Has AMP Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet Has specific active ingredient Acamprosate calcium true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet Has dispensed dose form Gastro-resistant oral tablet true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Acamprosate 333mg gastro-resistant tablets (Sigma Pharmaceuticals Plc) 168 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start